Repetitive Transcranial Magnetic Stimulation Alleviates Neurological Deficits After Cerebral Ischemia Through Interaction Between RACK1 and BDNF exon IV by the Phosphorylation-Dependent Factor MeCP2
Authors:
- 7 January 2020
- journal article
- research article
- Published by Elsevier in Neurotherapeutics
- Vol. 17 (2) , 651-663
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (No. 81471338 & No.81671284)
This publication has 45 references indexed in Scilit:
- Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampiJournal of Neuroinflammation, 2013
- NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptorsCell Death & Disease, 2013
- RACK1 Is a Ribosome Scaffold Protein for β-actin mRNA/ZBP1 ComplexPLOS ONE, 2012
- Nurr1 Protein Is Required for N-Methyl-d-aspartic Acid (NMDA) Receptor-mediated Neuronal SurvivalJournal of Biological Chemistry, 2012
- Modulation of cortical inhibition by rTMS – findings obtained from animal modelsThe Journal of Physiology, 2011
- Repetitive Transcranial Magnetic Stimulation Enhances BDNF-TrkB Signaling in Both Brain and LymphocyteThe Journal of Neuroscience, 2011
- Epigenetic Regulation of BDNF Expression via the Scaffolding Protein RACK1Journal of Biological Chemistry, 2010
- Repetitive transcranial magnetic stimulation at 1Hz and 5Hz produces sustained improvement in motor function and disability after ischaemic strokeEuropean Journal of Neurology, 2010
- Roles of NMDA receptor NR2A and NR2B subtypes for long‐term depression in the anterior cingulate cortexEuropean Journal of Neuroscience, 2005
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986